GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (FRA:7XP) » Definitions » Change In Other Working Capital

Organon (FRA:7XP) Change In Other Working Capital : €-136 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Organon Change In Other Working Capital?

Organon's Change In Other Working Capital for the quarter that ended in Mar. 2025 was €27 Mil. It means Organon's Other Working Capital increased by €27 Mil from Dec. 2024 to Mar. 2025 .

Organon's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was €-198 Mil. It means Organon's Other Working Capital declined by €198 Mil from Dec. 2023 to Dec. 2024 .

Organon Change In Other Working Capital Historical Data

The historical data trend for Organon's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Change In Other Working Capital Chart

Organon Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial -78.09 215.94 -48.14 5.50 -197.69

Organon Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.20 -84.54 11.71 -89.77 26.83

Organon Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-136 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organon Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Organon's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (FRA:7XP) » Definitions » Change In Other Working Capital
Comparable Companies
AMRN MDCX SCLX MIRA LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN MRK AMGN GILD PFE XPAR:SAN BMY TSE:4519 LSE:GSK TSE:4568
Traded in Other Exchanges
OGN:USA OGN:Mexico 1OGN:Italy 0A9W:UK 7XP:Germany
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Website
https://www.organon.com
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Organon Headlines

No Headlines